MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

    K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

    Objective: The aim of this study was to investigate how people with Parkinson´s disease experience an intervention of optimizing their own medical treatment through digitally…
  • 2023 International Congress

    Outcomes of patients treated with staged bilateral MRgHIFU thalamotomy using four-tract tractography targeting for medically refractory Essential Tremor

    N. Saez Calveras, D. Imphean, V. Sharma, L. Lanford, J. Viera, P. O'Suilleabhain, B. Shah (Dallas, USA)

    Objective: The goal of this study was to study the outcomes of 10 patients with medically refractory Essential Tremor (ET) treated with staged bilateral MR-guided…
  • 2023 International Congress

    Influence of Cognitive Function on Obstacle-Crossing Performance in People with Parkinson’s Disease: A Cross-Sectional Study

    HH. Hsu, RY. Wang, NC. Yeh, PL. Wong, CW. Hung (Taipei, Taiwan)

    Objective: This study investigated the influence of cognitive function on obstacle crossing performance in people with Parkinson's disease (PD). Background: Obstacle-crossing is a complex motor…
  • 2023 International Congress

    Blood derived α-synuclein seeding in the course of Parkinson’s Disease

    A. Kluge, E. Schaeffer, K. Brockmann, C. Schulte, C. Deuschle, J. Bunk, W. Maetzler, D. Berg (Kiel, Germany)

    Objective: To identify seeding capacities of soluble α-synuclein (α-syn) conformers derived from neuronal extracellular vesicles (NEs) from Parkinson´s disease (PD) patients with different disease durations…
  • 2023 International Congress

    Rasagiline in Chinese patients with early-stage parkinson’s disease: a randomized, double-blind, placebo-controlled, delayed-start trial

    W. Su, HJ. Liu, LJ. Wang, QY. Ye, L. Cao, HY. Zhou, XG. Luo, ZT. Ding, T. Wang, Q. Wang, HZ. Ma, EH. Xu, HB. Chen (Beijing, China)

    Objective: Objective: This randomized, double-blind, placebo-controlled, delayed-start trial aimed to investigate the efficacy in symptom improvement and disease-modifying effect of rasagiline for Chinese patients with…
  • 2023 International Congress

    Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

    S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

    Objective: To explore the regional cholinergic innervation and clinical profile of early Parkinson’s disease (PD) patients carrying GBA mutations (GBA-PD). Background: The most common genetic…
  • 2023 International Congress

    In vitro α–synuclein aggregation and propagation model

    F. Kapucu, I. Tujula, O. Kulta, L. Sukki, V. Vuolanto, A. Vinogradov, P. Kallio, S. Narkilahti (Tampere, Finland)

    Objective: Developing an in vitro α–synuclein (α-s) aggregation and propagation model of human cortical networks for functionality studies. Background: Studying α–s pathology and its effects…
  • 2023 International Congress

    Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson’s disease: A Systematic Review and Network Meta-Analysis

    SM. Li, YC. Zheng, C. Yang, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)

    Objective: We performed meta-analysis to determine the diagnostic and differential diagnostic value of α-syn SAAs for PD, and to investigate the optimal specimens. Background: Alpha-synuclein…
  • 2023 International Congress

    Diagnosis of Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy with 7T-MRI substantia nigra imaging

    D. Su, Z. Zhang, Z. Zhang, T. Wu, J. Jing, T. Feng (Beijing, China)

    Objective: To detect the signal change of nigrosome-1 in 7T-MRI and its diagnostic and differential diagnostic efficacy as the imaging biomarker of PD, MSA-P, MSA-C…
  • 2023 International Congress

    The spatial and spectral organization of thalamo-cortical connectivity in patients with essential tremor

    A. Steina, S. Schnitzler, J. Vesper, E. Florin, A. Schnitzler, J. Hirschmann (Düsseldorf, Germany)

    Objective: To identify cortical areas coupled to the ventral intermediate nucleus of the thalamus (VIM) in patients with essential tremor (ET). Background: ET is a…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley